Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era. [electronic resource]
- Alimentary pharmacology & therapeutics 05 2019
- 1126-1133 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
1365-2036
10.1111/apt.15201 doi
Antiviral Agents--economics Cost-Benefit Analysis Drug Costs Hepacivirus--isolation & purification Hepatitis C--diagnosis Hepatitis C, Chronic--diagnosis Humans Mass Screening--economics Quality-Adjusted Life Years Risk Factors